文献速递头颈外科

头颈癌患者自杀发生率的最新评估

Updated Incidence of Suicide Among Patients With Head and Neck Cancer.
PubMed 文献 · Laryngoscope · 2026-08-11

基于SEER 17登记处2012-2021年222,222例头颈癌患者数据,评估自杀发生率、时间趋势及危险因素。共298例自杀,发生率为33.53/10万人年,标准化死亡比(SMR)为1.90(95%CI 1.69-2.13)。男性、未婚、下咽癌、喉癌、单纯放疗或无手术/放疗者风险更高,多数自杀发生在诊断后5年内,部分癌种10年后风险仍持续升高。

要点

  • 头颈癌患者自杀风险为一般人群的1.90倍(SMR 1.90,95%CI 1.69-2.13)。
  • 下咽癌(SMR 4.18)和喉癌(SMR 2.95)患者自杀风险显著升高。
  • 男性、未婚、远处转移、单纯放疗或无手术/放疗者风险更高,应重点筛查。

核心结论

  • 头颈癌患者自杀SMR较早期队列有所下降,但研究期间一般人群自杀率上升,需谨慎解读。
  • 男性、未婚、下咽癌或喉癌、单纯放疗或无根治性治疗者自杀风险持续偏高。

研究设计与样本

  • 基于SEER 17登记处的回顾性队列研究,纳入2012-2021年诊断的222,222例头颈癌患者。
  • 自杀死亡通过SEER死因分类「suicide and self-inflicted injury」识别,计算年龄、性别、种族调整后的自杀发生率和标准化死亡比(SMR)。

主要发现

  • 共298例自杀,随访1.9百万人年,自杀发生率为33.53/10万人年,SMR为1.90(95%CI 1.69-2.13)。
  • 男性SMR为2.23,未婚者SMR为2.78,远处转移者SMR为2.87。
  • 下咽癌SMR为4.18,喉癌SMR为2.95;单纯放疗者SMR为3.23,未接受手术或放疗者SMR为5.39。
  • 多数自杀发生在诊断后5年内,口腔癌和口咽癌患者SMR为3.09;部分癌种10年后自杀风险仍升高。

临床怎么用

  • 对男性、未婚、下咽癌/喉癌、远处转移及未接受根治性治疗的头颈癌患者,应加强心理筛查和自杀风险评估。
  • 诊断后5年内为自杀高风险窗口,需持续关注心理状态。

局限性

  • 研究期间一般人群自杀率上升,SMR下降的解读需谨慎。
  • SEER数据可能未涵盖所有自杀相关因素,如心理社会干预等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess incidence, temporal trends, and risk factors for suicide among patients with HNC using Surveillance, Epidemiology, and End Results (SEER) data. METHODS: A total of 222,222 patients were diagnosed with HNC from the SEER 17 registries between 2012 and 2021. Suicide deaths were identified using the SEER cause-of-death category "suicide and self-inflicted injury." We calculated age-, sex-, and race-adjusted suicide incidence rates and standardized mortality ratios relative to the US general population. Risk factors analyzed included demographic variables, tumor site, disease stage, treatment modality, and time since diagnosis. RESULTS: There were 298 suicides among patients with HNC over 1.9 million person-years (33.53 per 100,000 person-years; SMR, 1.90; 95% CI, 1.69-2.13). Suicide rates were highest among men (SMR, 2.23), unmarried individuals (SMR, 2.78), and patients with distant metastatic disease (SMR, 2.87). Site-specific analysis showed elevated suicide risk for hypopharyngeal (SMR, 4.18) and laryngeal (SMR, 2.95) cancers. Radiation-only treatment was associated with a higher suicide rate (SMR, 3.23), as was receiving no surgery or radiation (SMR, 5.39). Most suicides occurred within 5 years of diagnosis, particularly among patients with oral cavity and oropharyngeal cancers (SMR, 3.09). In some cancers, elevated suicide risk persisted beyond 10 years. CONCLUSION: While there was an observed reduction in SMR relative to earlier cohorts, this should be interpreted cautiously given rising general-population suicide rates during the study period. High-risk subgroups, including males, unmarried individuals, patients with cancer of the hypopharynx or larynx, and those receiving radiation alone or no definitive treatment, continue to face disproportionately elevated risk.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Saad AM, Herz D, Zhou C, et al. Updated Incidence of Suicide Among Patients With Head and Neck Cancer. Laryngoscope. 2026. PMID: 42578748. doi:10.1002/lary.70816

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。